Stockchase Opinions

Malvin Spooner PanGeo Pharma PIL.H-X BUY Jan 31, 2002

A good business and good franchises.
$3.240

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY
Earnings warnings were forcast. Seems to be corrected now. Cheap.
DON'T BUY
Likes this sector, but they just gave a lower guidance.
BUY
Has warned a few times. Making some strategic moves in beefing up their management. A reasonable bet.
DON'T BUY
Made a good move in splitting the offices of the chairman and the CEO. They are trying to deal with their problems. Have to see an improvement before there is any interest.
DON'T BUY
Have had some pretty big earnings misses and management issues. May be a take over target at some point. Wait for it to drop further.
DON'T BUY
Very extended. Squeezing their credit lines and suppliers. Have to earn $0.10 a share to support the liquidity issue.
DON'T BUY
In a very defined downtrend.
DON'T BUY
Auditors left and have to be replaced and trading has been stopped until their reports are in.
DON'T BUY
Doesn't look good.
DON'T BUY
Trading has been stopped. Plagued by a number of problems. Waiting for the company to complete its audit.